---
figid: PMC7796017__ijms-22-00173-g002
figtitle: PI3K/AKT/mTOR signaling pathway and breast cancer
organisms:
- Saccharomyces cerevisiae
- Nicotiana tabacum
- Corynocarpus laevigatus
- Homo sapiens
- Rattus norvegicus
- Molva molva
organisms_ner:
- Rattus norvegicus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC7796017
filename: ijms-22-00173-g002.jpg
figlink: pmc/articles/PMC7796017/figure/ijms-22-00173-f002/
number: F2
caption: The PI3K/AKT/mTOR signaling pathway and breast cancer. The PI3K/AKT/mTOR
  signaling pathway is activated by ER, but also by EGFR, HER 2, IGFR1R, and FGFR1
  at RTKs level. Once activated, protein kinase B or AKT inhibits TSC ½ by phosphorylation,
  further leading to the inhibition of Rheb and activation of mTORC1. This activation
  is associated with anti-apoptotic effects, increased gene expression, cell proliferation
  and angiogenesis. Everolimus and temsirolimus are two analogues of rapamycin that
  inhibit the activity of mTOR, especially mTORC1, but also mTORC2.
papertitle: 'PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape
  to Clinical Aspects.'
reftext: Daniela Miricescu, et al. Int J Mol Sci. 2021 Jan;22(1):173.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7843952
figid_alias: PMC7796017__F2
figtype: Figure
redirect_from: /figures/PMC7796017__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7796017__ijms-22-00173-g002.html
  '@type': Dataset
  description: The PI3K/AKT/mTOR signaling pathway and breast cancer. The PI3K/AKT/mTOR
    signaling pathway is activated by ER, but also by EGFR, HER 2, IGFR1R, and FGFR1
    at RTKs level. Once activated, protein kinase B or AKT inhibits TSC ½ by phosphorylation,
    further leading to the inhibition of Rheb and activation of mTORC1. This activation
    is associated with anti-apoptotic effects, increased gene expression, cell proliferation
    and angiogenesis. Everolimus and temsirolimus are two analogues of rapamycin that
    inhibit the activity of mTOR, especially mTORC1, but also mTORC2.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egfr
  - Igf1r
  - Fgfr1
  - Rictor
  - Akt1
  - Mtor
  - Pik3cg
  - Mlst8
  - Rheb
  - Akt1s1
  - EGFR
  - ERBB2
  - IGF1R
  - FGFR1
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - RHEB
  - RHEBP1
  - RPTOR
  - AKT1S1
  - btl
  - Tie
  - Ras85D
  - InR
  - rictor
  - Akt
  - Tor
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Crtc
  - raptor
  - PRAS40
  - Everolimus
  - Temsirolimus
---
